Adjunctive therapies in sepsis

Jay F. Rilinger*, Elora Hussain, Mary E. McBride

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The past several decades have seen the proposal of many novel therapies for sepsis, but none have been successfully introduced into current standard practice. Anti-inflammatory therapies seek to quell the overwhelming inflammation and coagulation dysregulation most often present during sepsis onset. More recently, immunostimulatory therapies have been investigated, seeking to rescue the paralyzed immune system that often develops later in the course of sepsis leading to secondary nosocomial infections and death. Other approaches include renal replacement therapies and plasma exchange, which attempt to remove sepsis proinflammatory and anti-inflammatory mediators nonspecifically. While we await an effective drug or therapy, current investigations with novel approaches are presented here.

Original languageEnglish (US)
Pages (from-to)204-213
Number of pages10
JournalClinical Pediatric Emergency Medicine
Issue number2
StatePublished - Jun 2014


  • Adjunctive
  • Adjuvant
  • Pediatric
  • Review
  • Sepsis
  • Therapies
  • Treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Emergency Medicine

Fingerprint Dive into the research topics of 'Adjunctive therapies in sepsis'. Together they form a unique fingerprint.

Cite this